ESR1 and breast carcinoma: Furthermore, 70% of patients with primary breast tumors experience ER+, and ER+ breast cancer has a high tendency to metastasize to distant sites; in particular, bone metastasis is most frequently observed, which is a major cause of breast cancer-associated morbidity and mortality [11,12].